Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 24,122 PHAT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 24,122 | n/a |
| Jun 5, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 10,500 | n/a |
| Jun 11, 2024 | Sage Therapeutics, Inc. (SAGE) | Grant/Award | 12,500 | n/a |
| May 24, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 10,500 | n/a |
| May 30, 2023 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 9,000 | n/a |
| May 27, 2022 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 15,000 | n/a |
| Feb 19, 2022 | Phathom Pharmaceuticals, Inc. (PHAT) | Purchase | 9,798 | $186.2K |
| Oct 4, 2021 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 78,116 | n/a |
| Jul 2, 2021 | Cerecor Inc. (CERC) | Grant/Award | 51,740 | n/a |
| May 24, 2021 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 12,500 | n/a |